Fred's, Inc.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
|
|
|
þ |
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. |
For the quarterly period ended August 4, 2007.
OR
|
|
|
o |
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF
1934. |
For
the transition period from
to .
Commission file number 001-14565
FREDS, INC.
(Exact name of registrant as specified in its charter)
|
|
|
Tennessee
|
|
62-0634010 |
(State or other jurisdiction of
|
|
(I.R.S. Employer |
incorporation or organization)
|
|
Identification No.) |
|
|
|
4300 New Getwell Rd., Memphis, Tennessee
|
|
38118 |
(Address of principal executive offices)
|
|
(zip code) |
(901) 365-8880
(Registrants telephone number, including area code)
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by
Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for
such shorter period that the registrant was required to file such reports), and (2) has been
subject to such filing requirements for the past 90 days.
Yes þ No o.
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer,
or a non-accelerated filer. See definition of accelerated filer and large accelerated filer in
Rule 12b-2 of the Exchange Act.
Large accelerated filer o Accelerated filer þ Non-accelerated filer o
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the
Exchange Act. Yes o No þ.
The registrant had 40,177,050 shares of Class A voting, no par value common stock outstanding as of
September 7, 2007.
Part 1 FINANCIAL INFORMATION
Item 1. FINANCIAL STATEMENTS
FREDS, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands, except for number of shares)
|
|
|
|
|
|
|
|
|
|
|
August 4, |
|
|
February 3, |
|
|
|
2007 |
|
|
2007 |
|
|
|
(unaudited) |
|
|
|
|
|
ASSETS: |
|
|
|
|
|
|
|
|
Current assets: |
|
|
|
|
|
|
|
|
Cash and cash equivalents |
|
$ |
2,302 |
|
|
$ |
2,475 |
|
Inventories |
|
|
347,594 |
|
|
|
304,969 |
|
Receivables, less allowance for doubtful
accounts of $767 and $719, respectively |
|
|
26,349 |
|
|
|
29,097 |
|
Other non-trade receivables |
|
|
18,476 |
|
|
|
18,953 |
|
Prepaid expenses and other current assets |
|
|
10,604 |
|
|
|
12,224 |
|
|
|
|
|
|
|
|
Total current assets |
|
|
405,325 |
|
|
|
367,718 |
|
Property and equipment, at depreciated cost |
|
|
139,070 |
|
|
|
138,031 |
|
Equipment under capital leases, less accumulated
amortization of $4,725 and $4,578, respectively |
|
|
242 |
|
|
|
390 |
|
Other noncurrent assets, net |
|
|
9,060 |
|
|
|
9,570 |
|
|
|
|
|
|
|
|
Total assets |
|
$ |
553,697 |
|
|
$ |
515,709 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND SHAREHOLDERS EQUITY |
|
|
|
|
|
|
|
|
Current liabilities: |
|
|
|
|
|
|
|
|
Accounts payable |
|
$ |
67,117 |
|
|
$ |
64,349 |
|
Current portion of indebtedness |
|
|
849 |
|
|
|
385 |
|
Current portion of capital lease obligations |
|
|
276 |
|
|
|
352 |
|
Accrued expenses and other |
|
|
39,552 |
|
|
|
42,159 |
|
Deferred income taxes |
|
|
14,635 |
|
|
|
16,396 |
|
Income taxes payable |
|
|
|
|
|
|
4,188 |
|
|
|
|
|
|
|
|
Total current liabilities |
|
|
122,429 |
|
|
|
127,829 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Long-term portion of indebtedness |
|
|
32,883 |
|
|
|
2,216 |
|
Deferred income taxes |
|
|
11,550 |
|
|
|
12,425 |
|
Capital lease obligations, long term portion |
|
|
|
|
|
|
115 |
|
Other noncurrent liabilities |
|
|
11,072 |
|
|
|
3,856 |
|
|
|
|
|
|
|
|
Total liabilities |
|
|
177,934 |
|
|
|
146,441 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Commitments and Contingencies |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shareholders equity: |
|
|
|
|
|
|
|
|
Preferred stock, nonvoting, no par value,
10,000,000 shares authorized, none outstanding |
|
|
|
|
|
|
|
|
Preferred stock, Series A junior participating
nonvoting, no par value, 224,594 shares
authorized, none outstanding |
|
|
|
|
|
|
|
|
Common stock, Class A voting, no par value,
60,000,000 shares authorized, 40,131,686
and 40,068,953 shares issued and outstanding,
respectively |
|
|
137,649 |
|
|
|
135,803 |
|
Common stock, Class B nonvoting, no par value,
11,500,000 shares authorized, none outstanding |
|
|
|
|
|
|
|
|
Retained earnings |
|
|
237,063 |
|
|
|
232,382 |
|
Accumulated other comprehensive income |
|
|
1,051 |
|
|
|
1,083 |
|
|
|
|
|
|
|
|
Total shareholders equity |
|
|
375,763 |
|
|
|
369,268 |
|
|
|
|
|
|
|
|
Total liabilities and shareholders equity |
|
$ |
553,697 |
|
|
$ |
515,709 |
|
|
|
|
|
|
|
|
See accompanying notes to condensed consolidated financial statements.
3
FREDS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(unaudited)
(in thousands, except share and per share amounts)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Thirteen Weeks Ended |
|
|
Twenty-six Weeks Ended |
|
|
|
August 4, |
|
|
July 29, |
|
|
August 4, |
|
|
July 29, |
|
|
|
2007 |
|
|
2006 |
|
|
2007 |
|
|
2006 |
|
Net sales |
|
$ |
424,640 |
|
|
$ |
406,925 |
|
|
$ |
866,902 |
|
|
$ |
823,803 |
|
Cost of goods sold |
|
|
303,157 |
|
|
|
291,881 |
|
|
|
618,418 |
|
|
|
588,915 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross profit |
|
|
121,483 |
|
|
|
115,044 |
|
|
|
248,484 |
|
|
|
234,888 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation and amortization |
|
|
7,408 |
|
|
|
7,013 |
|
|
|
14,635 |
|
|
|
14,122 |
|
Selling, general and
administrative expenses |
|
|
108,373 |
|
|
|
101,826 |
|
|
|
216,990 |
|
|
|
203,513 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income |
|
|
5,702 |
|
|
|
6,205 |
|
|
|
16,859 |
|
|
|
17,253 |
|
Interest income |
|
|
(158 |
) |
|
|
(15 |
) |
|
|
(291 |
) |
|
|
(62 |
) |
Interest expense |
|
|
395 |
|
|
|
235 |
|
|
|
432 |
|
|
|
277 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income before income taxes |
|
|
5,465 |
|
|
|
5,985 |
|
|
|
16,718 |
|
|
|
17,038 |
|
Provision for income taxes |
|
|
2,407 |
|
|
|
1,662 |
|
|
|
6,222 |
|
|
|
5,417 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
$ |
3,058 |
|
|
$ |
4,323 |
|
|
$ |
10,496 |
|
|
$ |
11,621 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income per share |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic |
|
$ |
.08 |
|
|
$ |
.11 |
|
|
$ |
.26 |
|
|
$ |
.29 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted |
|
$ |
.08 |
|
|
$ |
.11 |
|
|
$ |
.26 |
|
|
$ |
.29 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average shares outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic |
|
|
39,864 |
|
|
|
39,753 |
|
|
|
39,851 |
|
|
|
39,732 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Effect of dilutive stock options |
|
|
118 |
|
|
|
96 |
|
|
|
123 |
|
|
|
99 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted |
|
|
39,982 |
|
|
|
39,849 |
|
|
|
39,974 |
|
|
|
39,831 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dividends per common share |
|
$ |
.02 |
|
|
$ |
.02 |
|
|
$ |
.04 |
|
|
$ |
.04 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Comprehensive income: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
$ |
3,058 |
|
|
$ |
4,323 |
|
|
$ |
10,496 |
|
|
$ |
11,621 |
|
Other comprehensive income
(expense), net of tax
Postretirement plan adjustment |
|
|
(16 |
) |
|
|
|
|
|
|
(32 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Comprehensive income |
|
$ |
3,042 |
|
|
$ |
4,323 |
|
|
$ |
10,464 |
|
|
$ |
11,621 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
See accompanying notes to condensed consolidated financial statements.
4
FREDS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(unaudited)
(in thousands)
|
|
|
|
|
|
|
|
|
|
|
Twenty-six Weeks Ended |
|
|
|
August 4, |
|
|
July 29, |
|
|
|
2007 |
|
|
2006 |
|
Cash flows from operating activities: |
|
|
|
|
|
|
|
|
Net income |
|
$ |
10,496 |
|
|
$ |
11,621 |
|
Adjustments to reconcile net income
to net cash flows from operating activities: |
|
|
|
|
|
|
|
|
Depreciation and amortization |
|
|
14,635 |
|
|
|
14,122 |
|
Net loss on asset disposition |
|
|
48 |
|
|
|
15 |
|
Stock-based compensation |
|
|
1,117 |
|
|
|
1,086 |
|
Provision for (recovery of) uncollectible receivables |
|
|
48 |
|
|
|
(40 |
) |
LIFO reserve increase |
|
|
921 |
|
|
|
1,632 |
|
Deferred income tax expense (benefit) |
|
|
(2,636 |
) |
|
|
647 |
|
Provision for postretirement medical |
|
|
(32 |
) |
|
|
|
|
Excess tax benefits (charges)from
stock-based compensation |
|
|
7 |
|
|
|
(56 |
) |
(Increase)decrease in assets: |
|
|
|
|
|
|
|
|
Trade receivables |
|
|
1,545 |
|
|
|
(8,284 |
) |
Insurance receivables |
|
|
982 |
|
|
|
2,410 |
|
Inventories |
|
|
(43,546 |
) |
|
|
(35,152 |
) |
Other assets |
|
|
1,620 |
|
|
|
1,723 |
|
Increase (decrease) in liabilities: |
|
|
|
|
|
|
|
|
Accounts payable and accrued expenses |
|
|
161 |
|
|
|
7,709 |
|
Income taxes payable |
|
|
(4,195 |
) |
|
|
(6,140 |
) |
Other noncurrent liabilities |
|
|
3,003 |
|
|
|
392 |
|
|
|
|
|
|
|
|
Net cash used in operating activities |
|
|
(15,826 |
) |
|
|
(8,315 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from investing activities: |
|
|
|
|
|
|
|
|
Capital expenditures |
|
|
(12,770 |
) |
|
|
(11,373 |
) |
Proceeds from asset dispositions |
|
|
280 |
|
|
|
98 |
|
Insurance recoveries for replacement assets |
|
|
650 |
|
|
|
282 |
|
Asset acquisitions, net (primarily intangibles) |
|
|
(695 |
) |
|
|
(2,861 |
) |
|
|
|
|
|
|
|
Net cash used in investing activities |
|
|
(12,535 |
) |
|
|
(13,854 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from financing activities: |
|
|
|
|
|
|
|
|
Payments of indebtedness and capital lease obligations |
|
|
(575 |
) |
|
|
(665 |
) |
Proceeds from revolving line of credit, net of payments |
|
|
30,068 |
|
|
|
22,811 |
|
Excess tax benefits from stock-based compensation |
|
|
(7 |
) |
|
|
56 |
|
Proceeds from exercise of stock options and issuances
under employee stock purchase plan |
|
|
305 |
|
|
|
901 |
|
Cash dividends paid |
|
|
(1,603 |
) |
|
|
(1,596 |
) |
|
|
|
|
|
|
|
Net cash provided by financing activities |
|
|
28,188 |
|
|
|
21,507 |
|
|
|
|
|
|
|
|
Increase (decrease) in cash and cash equivalents |
|
|
(173 |
) |
|
|
(662 |
) |
Beginning of period cash and cash equivalents |
|
|
2,475 |
|
|
|
3,145 |
|
|
|
|
|
|
|
|
End of period cash and cash equivalents |
|
$ |
2,302 |
|
|
$ |
2,483 |
|
|
|
|
|
|
|
|
Supplemental disclosures of cash flow information: |
|
|
|
|
|
|
|
|
Interest paid |
|
$ |
442 |
|
|
$ |
207 |
|
|
|
|
|
|
|
|
Income taxes paid |
|
$ |
14,200 |
|
|
$ |
13,141 |
|
|
|
|
|
|
|
|
Non-cash investing and financial activities: |
|
|
|
|
|
|
|
|
Assets acquired with term loan |
|
$ |
1,447 |
|
|
$ |
100 |
|
|
|
|
|
|
|
|
Common stock
issued for purchase of capital assets |
|
$ |
432 |
|
|
$ |
|
|
|
|
|
|
|
|
|
See accompanying notes to condensed consolidated financial statements.
5
FREDS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
NOTE 1: BASIS OF PRESENTATION
Freds and its subsidiaries (We, Our, Us or Company) operate, as of August 4,
2007, 701 discount general merchandise stores, including 24 franchised Freds stores, in 15
states in the southeastern United States. 294 of the stores have full service pharmacies.
The accompanying unaudited consolidated financial statements have been prepared in
accordance with U.S. generally accepted accounting principles (GAAP) for interim financial
information and are presented in accordance with the requirements of Form 10-Q and therefore
do not include all information and notes necessary for a fair presentation of financial
position, results of operations and cash flows in conformity with GAAP. The statements do
reflect all adjustments (consisting of only normal recurring accruals), which are, in the
opinion of management, necessary for a fair presentation of financial position in conformity
with GAAP. The statements should be read in conjunction with the Notes to the Consolidated
Financial Statements for the fiscal year ended February 3, 2007
incorporated into our Annual
Report on Form 10-K.
The results of operations for the twenty-six week period ended August 4, 2007 are not
necessarily indicative of the results to be expected for the full fiscal year.
NOTE 2: RECENT ACCOUNTING PRONOUNCEMENTS
In September 2006, the Financial Accounting Standards Board issued Statement of Financial
Accounting Standards No. 157, Fair Value Measurements, (SFAS No. 157) which is effective
for fiscal years beginning after November 15, 2007 and for interim periods within those
years. This statement defines fair value, establishes a framework for measuring fair value
and expands the related disclosure requirements. This statement is effective for our 2008
fiscal year, although early adoption is permitted. The Company is in the process of
determining the effect, if any, that the adoption of SFAS 157 will have on its results of
operations or financial position.
In February 2007, the Financial Accounting Standards Board issued SFAS No. 159, The Fair
Value Option for Financial Assets and Financial LiabilitiesIncluding an Amendment of FASB
Statement No. 115, (SFAS No. 159). SFAS No. 159 allows companies the choice to measure
many financial instruments and certain other items at fair value. This gives a company the
opportunity to mitigate volatility in reported earnings caused by measuring related assets
and liabilities differently without having to apply complex hedge accounting provisions. SFAS
No. 159 is effective for fiscal years beginning after November 15, 2007. We are currently
reviewing the impact of SFAS No. 159, if any, on our Consolidated Financial Statements and
expect to complete this evaluation in 2007.
In March 2007, the Emerging Issues Task Force (EITF) reached a consensus on issue number
06-10, Accounting for Deferred Compensation and Postretirement Benefit Aspects of Collateral
Assignment Split-Dollar Life Insurance Arrangements, (EITF 06-10). EITF 06-10 provides
guidance to help companies determine whether a liability for the postretirement benefit
associated with a collateral assignment split-dollar life insurance arrangement should be
recorded in accordance with either SFAS No. 106, Employers Accounting for Postretirement
Benefits Other Than Pensions (if, in substance, a postretirement benefit plan exists), or
Accounting Principles Board Opinion No. 12 (if the arrangement is, in substance, an
individual deferred compensation contract). EITF 06-10 also provides guidance on how a
company should recognize and measure the asset in a collateral assignment split-dollar life
insurance contract. EITF 06-10 is effective for fiscal years beginning after December 15,
2007, although early adoption is permitted. The Company is in the process of determining the
effect, if any, that the adoption of EITF 06-10 will have on its results of operations or
financial position.
6
NOTE 3: INVENTORIES
Merchandise inventories are valued at the lower of cost or market using the retail first-in,
first-out (FIFO) method for goods in our stores and the cost FIFO method for goods in our
distribution centers. The retail inventory method is a reverse mark-up, averaging method
which has been widely used in the retail industry for many years. This method calculates a
cost-to-retail ratio that is applied to the retail value of inventory to determine the cost
value of inventory and the resulting cost of goods sold and gross margin. The assumption
that the retail inventory method provides for valuation at lower of cost or market and the
inherent uncertainties therein are discussed in the following paragraphs.
In order to assure valuation at the lower of cost or market, the retail value of our
inventory is adjusted on a consistent basis to reflect current market conditions. These
adjustments include increases to the retail value of inventory for initial markups to set the
selling price of goods or additional markups to adjust pricing for inflation and decreases to
the retail value of inventory for markdowns associated with promotional, seasonal or other
declines in the market value. Because these adjustments are made on a consistent basis and
are based on current prevailing market conditions, they approximate the carrying value of the
inventory at net realizable value (market value). Therefore, the cost value of our inventory
is stated at the lower of cost or market as is prescribed by U.S. GAAP.
Because the approximation of net realizable value (market value) under the retail inventory
method is based on estimates such as markups, markdowns and inventory losses (shrink) there
exists an inherent uncertainty in the final determination of inventory cost and gross margin.
In order to mitigate that uncertainty, the Company has a formal review by product class
which considers such variables as current market trends, seasonality, weather patterns and
age of merchandise to ensure that markdowns are taken currently, or a markdown reserve is
established to cover future anticipated markdowns. This review also considers current
pricing trends and inflation to ensure that markups are taken if necessary. The estimation
of inventory losses is a significant element in approximating the carrying value of inventory
at net realizable value, and as such the following paragraph describes our estimation method
as well as the steps we take to mitigate the risk of this estimate in the determination of
the cost value of inventory.
The Company calculates inventory losses (shrink) based on actual inventory losses occurring
as a result of physical inventory counts during each fiscal period and estimated inventory
losses occurring between yearly physical inventory counts. The estimate for shrink occurring
in the interim period between physical counts is calculated on a store- specific basis and is
based on history, as well as performance on the most recent physical count. It is calculated
by multiplying each stores shrink rate, which is based on the previously mentioned factors,
by the interim periods sales for each store. Additionally, the overall estimate for shrink
is adjusted at the corporate level to a three-year historical average to ensure that the
overall shrink estimate is the most accurate approximation of shrink based on the Companys
overall history of shrink. The three-year historical estimate is calculated by dividing the
book to physical inventory adjustments for the trailing 36 months by the related sales for
the same period.
In order to reduce the uncertainty inherent in the shrink calculation, the Company first
performs the calculation at the lowest practical level (by store) using the most current
performance indicators. This ensures a more reliable number, as opposed to using a higher
level aggregation or percentage method. The second portion of the calculation ensures that
the extreme negative or positive performance of any particular store or group of stores does
not skew the overall estimation of shrink. This portion of the calculation removes
additional uncertainty by eliminating short-term peaks and valleys that could otherwise cause
the underlying carrying cost of inventory to fluctuate unnecessarily. The Company has not
experienced any significant change in shrink as a percentage of sales from year to year
during the subject reporting periods.
Management believes that the Companys retail inventory method provides an inventory
valuation which reasonably approximates cost and results in carrying inventory at the lower
of cost or market. For pharmacy inventories, which were approximately $34.3 million and $36.4
million at August 4, 2007 and February 3, 2007, respectively, cost was determined using the
retail last-in, first-
7
out (LIFO)
method in which inventory cost is maintained using the retail inventory method, then adjusted
by application of the Producer Price Index published by the U.S. Department of Labor for the
cumulative annual periods. The current cost of inventories exceeded the LIFO cost by
approximately $14.7 million at August 4, 2007 and $13.8 million at February 3, 2007.
The Company has historically included an estimate of inbound freight and certain general and
administrative expenses in merchandise inventory as prescribed by Generally Accepted Accounting
Principles. These costs include activities surrounding the procurement and storage of merchandise
inventory such as buying, warehousing, and accounting, as well as inbound freight. During the
quarter ended August 4, 2007, we revised our estimate to include certain costs internally captured
within our Merchandise Planning, Information Technology and Human Resources departments as they
relate to the inventory functions and support of procurement and storage. This revision follows
growth in the role of these departments in support of the procurement and warehousing functions,
including additional personnel hired over the past few quarters. Further, our Merchandise Planning
department has evolved from being previously included within the buying function to a stand alone
function with responsibility for inbound logistics and commodity procurement. The inclusion of
these expenses in the estimate resulted in an additional $1.1 million pretax or $.02 of earnings
per share being capitalized as part of merchandise inventory. The total amount of expenses and
inbound freight included in merchandise inventory as of the end of the second quarter is $22.7
million.
NOTE 4: EQUITY INCENTIVE PLANS
Incentive stock option plan:
The Company accounts for its stock-based compensation plans in accordance with Statement of
Financial Accounting Standards No. 123(R), Share-Based Payment,(SFAS No. 123(R)). Under
SFAS No. 123(R) stock-based compensation expense is based on awards ultimately expected to
vest, and therefore has been reduced for estimated forfeitures. Forfeitures are estimated at
the time of grant based on the Companys historical forfeiture experience and will be revised
in subsequent periods if actual forfeitures differ from those estimates.
SFAS 123(R) also requires the benefits of income tax deductions in excess of recognized
compensation cost to be reported as a financing cash flow, rather than as an operating cash
flow as required prior to SFAS 123(R).
A summary of the Companys stock-based compensation (a component of selling, general and
administrative expenses) and related income tax benefit is as follows (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Thirteen Weeks Ended |
|
|
Twenty-Six Weeks Ended |
|
|
|
August 4, |
|
|
July 29, |
|
|
August 4, |
|
|
July 29, |
|
|
|
2007 |
|
|
2006 |
|
|
2007 |
|
|
2006 |
|
Stock option expense |
|
$ |
255 |
|
|
$ |
558 |
|
|
$ |
739 |
|
|
$ |
710 |
|
Restricted stock expense |
|
|
134 |
|
|
|
115 |
|
|
|
274 |
|
|
|
222 |
|
ESPP expense |
|
|
52 |
|
|
|
65 |
|
|
|
104 |
|
|
|
154 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total stock-based compensation |
|
|
441 |
|
|
|
738 |
|
|
|
1,117 |
|
|
|
1,086 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income tax benefit on stock-based
compensation |
|
|
54 |
|
|
|
56 |
|
|
|
168 |
|
|
|
94 |
|
The fair value of each option granted during the periods indicated in the following table
(there were no grants for the thirteen weeks ended August 4, 2007) are estimated on the date
of grant using the Black-Scholes option-pricing model with the following weighted average
assumptions:
8
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Thirteen Weeks Ended |
|
Twenty-Six Weeks Ended |
|
|
August 4, |
|
July 29, |
|
August 4, |
|
July 29, |
|
|
2007 |
|
2006 |
|
2007 |
|
2006 |
Stock Options |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expected volatility |
|
|
N/A |
|
|
|
41.6 |
% |
|
|
41.0 |
% |
|
|
41.5 |
% |
Risk-free interest rate |
|
|
N/A |
|
|
|
4.4 |
% |
|
|
4.4 |
% |
|
|
4.8 |
% |
Expected option life
(in years) |
|
|
N/A |
|
|
|
5.84 |
|
|
|
5.84 |
|
|
|
5.84 |
|
Expected dividend yield |
|
|
N/A |
|
|
|
0.35 |
% |
|
|
0.40 |
% |
|
|
0.35 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average fair
value at grant date |
|
|
N/A |
|
|
$ |
6.05 |
|
|
$ |
6.49 |
|
|
$ |
6.15 |
|
Employee Stock Purchase Plan |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expected volatility |
|
|
42.3 |
% |
|
|
33.5 |
% |
|
|
37.5 |
% |
|
|
33.5 |
% |
Risk-free interest rate |
|
|
4.7 |
% |
|
|
4.8 |
% |
|
|
4.7 |
% |
|
|
4.8 |
% |
Expected option life
(in years) |
|
|
0.5 |
|
|
|
0.5 |
|
|
|
0.38 |
|
|
|
0.38 |
|
Expected dividend yield |
|
|
0.30 |
% |
|
|
0.13 |
% |
|
|
0.23 |
% |
|
|
0.13 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average fair
value at grant date |
|
$ |
3.36 |
|
|
$ |
3.91 |
|
|
$ |
3.01 |
|
|
$ |
3.67 |
|
The following is a summary of the methodology applied to develop each assumption:
Expected Volatility This is a measure of the amount by which a price has
fluctuated or is expected to fluctuate. The Company uses actual historical changes in
the market value of our stock to calculate expected price volatility because
management believes that this is the best indicator of future volatility. The Company
calculates weekly market value changes from the date of grant over a past period
representative of the expected life of the options to determine volatility. An
increase in the expected volatility will increase compensation expense.
Risk-free Interest Rate This is the yield of a U.S. Treasury zero-coupon
bond issue effective at the grant date with a remaining term equal to the expected
life of the option. An increase in the risk-free interest rate will increase
compensation expense.
Expected Lives This is the period of time over which the options granted are
expected to remain outstanding and is based on historical experience. Options granted
have a maximum term of seven and one-half years. An increase in the expected life will
increase compensation expense.
Dividend Yield This is based on the historical yield for a period equivalent
to the expected life of the option. An increase in the dividend yield will decrease
compensation expense.
Forfeiture Rate This is the estimated percentage of options granted
that are expected to be forfeited or cancelled before becoming fully vested. This
estimate is based on historical experience. An increase in the forfeiture rate will
decrease compensation expense.
Employee stock purchase plan.
The 2004 Employee Stock Purchase Plan (the 2004 Plan), which was approved by Freds
stockholders, permits eligible employees to purchase shares of our common stock through
payroll deductions at the lower of 85% of the fair market value of the stock at the time of
grant or 85% of the fair market value at the time of exercise. There were 32,336 shares
issued during the twenty-six weeks ended August 4, 2007. There are 1,410,928 shares approved
to be issued under the 2004 Plan and as of august 4, 2007, there were 1,262,905 shares
available.
9
Stock Options
The following table summarizes stock option activity during the twenty-six weeks ended August
4, 2007:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted |
|
|
|
|
|
|
|
|
Weighted |
|
Average |
|
Aggregate |
|
|
|
|
|
|
Average |
|
Remaining |
|
Intrinsic |
|
|
|
|
|
|
Exercise |
|
Contractual |
|
Value |
|
|
Options |
|
Price |
|
Life (Years) |
|
(Thousands) |
Outstanding at February 3, 2007 |
|
|
1,103,064 |
|
|
$ |
16.74 |
|
|
|
4.2 |
|
|
$ |
298 |
|
Granted |
|
|
17,500 |
|
|
$ |
14.73 |
|
|
|
|
|
|
|
|
|
Forfeited / Cancelled |
|
|
(26,250 |
) |
|
$ |
19.60 |
|
|
|
|
|
|
|
|
|
Exercised |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding at August 4, 2007 |
|
|
1,094,314 |
|
|
$ |
16.64 |
|
|
|
3.8 |
|
|
$ |
0 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercisable at August 4, 2007 |
|
|
403,203 |
|
|
$ |
17.37 |
|
|
|
2.9 |
|
|
$ |
0 |
|
The aggregate intrinsic value in the table above represents the total pre-tax intrinsic value
(the difference between Freds closing stock price of $11.53 on the last trading day of the
period ended August 4, 2007 and the exercise price of the option multiplied by the number of
in-the-money options) that would have been received by the option holders had all option
holders exercised their options on that date. As of August 4, 2007, total unrecognized
stock-based compensation expense net of estimated forfeitures related to non-vested stock
options was approximately $1.43 million, which is expected to be recognized over a weighted
average period of approximately 2.8 years. The total fair value of options vested during the
twenty-six weeks ended August 4, 2007 was $.58 million.
Restricted Stock
The following table summarizes restricted stock activity during the twenty-six weeks ended
August 4, 2007:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted |
|
|
|
|
|
|
Average |
|
|
Number |
|
Grant Date |
|
|
of Shares |
|
Fair Value |
Non-vested Restricted Stock at February 3, 2007 |
|
|
229,851 |
|
|
$ |
15.03 |
|
Granted |
|
|
534 |
|
|
$ |
14.98 |
|
Forfeited / Cancelled |
|
|
(389 |
) |
|
$ |
14.46 |
|
Vested |
|
|
(6,619 |
) |
|
$ |
17.62 |
|
|
|
|
|
|
|
|
|
|
Non-vested Restricted Stock at August 4, 2007 |
|
|
223,377 |
|
|
$ |
15.04 |
|
The aggregate pre-tax intrinsic value of restricted stock outstanding as of August 4, 2007 is
$2.6 million with a weighted average remaining contractual life of 6.9 years. The
unrecognized compensation expense net of estimated forfeitures, related to the outstanding
stock is approximately $2.4 million, which is expected to be recognized over a weighted
average period of approximately 6.5 years. The total fair value of restricted stock awards
that vested during the twenty-six weeks ended August 4, 2007 was $.11 million.
NOTE 5: Property and Equipment
10
Property and Equipment are carried at cost. Depreciation is recorded using the
straight-line method over the estimated useful lives of the assets. Improvements to leased
premises are amortized using the straight-line method over the shorter of the initial term
of the lease or the useful life of the improvement. Leasehold improvements added late in
the lease term are amortized over the shorter of the remaining term of the lease (including
the upcoming renewal option, if the renewal is reasonably assured) or the useful life of the
improvement. Assets under capital leases are amortized in accordance with the Companys
normal depreciation policy for owned assets or over the lease term (regardless of renewal
options), if shorter, and the charge to earnings is included in depreciation expense in the
consolidated financial statements. Gains or losses on the sale of assets are recorded at
disposal as a component of operating income. The following illustrates the breakdown of the
major categories within Property and Equipment:
|
|
|
|
|
|
|
|
|
|
|
August 4, |
|
|
February 3, |
|
|
|
2007 |
|
|
2007 |
|
|
|
(unaudited) |
|
|
|
|
|
Building and building improvements |
|
$ |
80,236 |
|
|
$ |
76,623 |
|
Furniture, fixtures and equipment |
|
|
220,891 |
|
|
|
216,448 |
|
Leasehold improvements |
|
|
48,311 |
|
|
|
45,097 |
|
Automobiles and vehicles |
|
|
6,555 |
|
|
|
6,429 |
|
Airplane |
|
|
4,697 |
|
|
|
4,697 |
|
|
|
|
|
|
|
|
|
|
|
360,690 |
|
|
|
349,294 |
|
|
|
|
|
|
|
|
|
|
Less: Accumulated Depreciation and
Amortization |
|
|
(226,792 |
) |
|
|
(215,879 |
) |
|
|
|
|
|
|
|
|
|
|
133,898 |
|
|
|
133,415 |
|
Construction in Progress |
|
|
814 |
|
|
|
353 |
|
Land |
|
|
4,358 |
|
|
|
4,263 |
|
|
|
|
|
|
|
|
Total Property and Equipment, at
depreciated cost |
|
$ |
139,070 |
|
|
$ |
138,031 |
|
|
|
|
|
|
|
|
During the second quarter of fiscal 2007, the Company acquired the land and building,
occupied by three Freds stores which we had previously leased. In consideration for the
three properties, the Company paid cash of $.425 million, issued 32,578 shares of our common
stock valued at $.432 million and assumed debt of $.836 million current and $.611 million
long term. The long term debt has a fixed interest rate of 6.90% and matures on February 1,
2015. The Company intends to acquire an additional eleven properties consisting of land and
building presently leased by a Freds store through the issuance of our common stock,
assumption of debt and payment of cash.
NOTE 6: Income taxes
In June 2006, the Financial Accounting Standards Board issued FASB Interpretation No. 48
(FIN 48), Accounting for Uncertainty in Income Taxes an Interpretation of FASB
Statement No.109. We adopted FIN 48 as of February 4, 2007, the first day of fiscal
2007. This interpretation clarifies the accounting for uncertainty in income taxes recognized
in an enterprises financial statements in accordance with SFAS No. 109 and prescribes a
minimum recognition threshold of more-likely-than-not to be sustained upon examination that a
tax position must meet before being recognized in the financial statements. Under FIN 48, the
impact of an uncertain income tax position on the income tax return must be recognized at the
largest amount that is more-likely-than-not to be sustained upon audit by the relevant taxing
authority. An uncertain income tax position will not be recognized if it has less than a 50%
likelihood of being sustained. Additionally, FIN 48 provides guidance on de-recognition,
measurement, classification, interest and penalties, accounting in interim periods,
disclosure and transition.
As a result of the adoption of FIN 48, we recognized a cumulative effect adjustment of $4.2
million decrease to beginning retained earnings and a reclassification of certain amounts
between deferred income taxes ($2.3 million decrease) and other non-current liabilities ($6.5
million increase, including
11
$1.0 million of interest and penalties) to conform to the balance
sheet presentation requirements of FIN 48. During the first six months of 2007, our FIN 48
reserve increased by $0.2 million, including $0.1
million of accrued interest. The Company
includes potential interest and penalties recognized in accordance with FIN 48 in the
financial statements as a component of income tax expense.
The Company had approximately $8.0 million of unrecognized tax benefits as of August 4, 2007.
If recognized, approximately $5.9 million of the unrecognized tax benefits would affect the
Companys effective income tax rate.
We are subject to U.S. federal income tax as well as the income tax of multiple state
jurisdictions. The Company is open to federal and state tax audits until the applicable
statutes of limitation expire. The tax years 2000 through 2006 remain open to examination by
the major taxing jurisdictions to which we are subject.
NOTE 7: Exit and disposal activities
During the year ended February 3, 2007, the Company recorded a below-cost inventory
adjustment of approximately $1.2 million associated with the discontinuance of the boys and
girls apparel departments. Also the Company recorded an additional below-cost inventory
adjustment of $0.9 million for planned store closings. Both adjustments were recorded in
cost of goods sold in the consolidated statements of income for the year ended February 3,
2007.
The Company also recorded approximately $0.9 million in selling, general and administrative
expense in the consolidated statements of income for the year ended February 3, 2007 to
reflect impairment charges for furniture and fixtures and leasehold improvements relating to
the planned store closures mentioned above. Liability balances related to activities
discussed above for stores closed during the first six months ended August 4, 2007 are as
follows (in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Beginning |
|
Utilized during |
|
Ending |
|
|
Balance |
|
first 6 months |
|
Balance |
|
|
February 3, 2007 |
|
2007 |
|
August 4, 2007 |
|
Inventory markdowns for discontinuance of
boys & girls apparel |
|
$ |
1.2 |
|
|
$ |
0.8 |
|
|
$ |
0.4 |
|
Inventory markdowns for planned store closings |
|
|
0.9 |
|
|
|
0.7 |
|
|
|
0.2 |
|
Asset impairment for planned store closings |
|
|
0.9 |
|
|
|
0.5 |
|
|
|
0.4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
3.0 |
|
|
$ |
2.0 |
|
|
$ |
1.0 |
|
|
|
|
During the current year, the Company has incurred or expects to incur the following pretax
costs associated with said store closings (in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Estimated |
|
Incurred in |
|
|
|
|
Total |
|
2007 |
|
Remaining |
|
Lease contract termination costs |
|
$ |
1.7 |
|
|
$ |
1.4 |
|
|
$ |
0.3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
1.7 |
|
|
$ |
1.4 |
|
|
$ |
0.3 |
|
|
|
|
In addition to those stores that might be closed in the ordinary course of business, the
Company is planning approximately 20 store and pharmacy closings during the course of 2007
(16 of which have been closed as of August 4, 2007).
NOTE 8: Accumulated other comprehensive income
12
Accumulated Other Comprehensive Income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Twenty-Six Weeks Ended |
|
|
Year Ended |
|
|
|
August 4, |
|
|
July 29, |
|
|
February 3, |
|
(in thousands) |
|
2007 |
|
|
2006 |
|
|
2007 |
|
|
Accumulated other comprehensive income |
|
$ |
1,083 |
|
|
$ |
0 |
|
|
$ |
0 |
|
Adjustment to initially apply SFAS No. 158 (net of tax) |
|
|
|
|
|
|
|
|
|
|
1,083 |
|
Amortization of postretirement benefit |
|
|
(32 |
) |
|
|
0 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ending balance |
|
$ |
1,051 |
|
|
$ |
0 |
|
|
$ |
1,083 |
|
|
|
|
|
|
|
|
|
|
|
Effective February 3, 2007, the Company began recognizing the funded status of its
postretirement benefits plan in accordance with SFAS No. 158. SFAS No. 158 requires the
Company to display the net over-orunder funded position of a defined benefit postretirement
plan as an asset or liability, with any unrecognized prior service costs, transition
obligations or actuarial gains/losses reported as a component of accumulated other
comprehensive income in stockholders equity. The activity within accumulated other
comprehensive income in the first six months of 2007 represents the amortization of prior
service cost and net actuarial gains and losses through net periodic benefit cost.
Item 2:
Managements Discussion and Analysis of Financial
Condition and Results of Operations
GENERAL
Executive Overview
During the first six months of 2007, we continued our strategy of refreshing and revitalizing
our stores and capitalizing on our 60 years of experience in the discount retail sector. Our
Merchandise Refresher Program continued in the second quarter, reaching completion in
approximately 65% of our stores as of August 4, 2007. This program refreshes the look and feel
of our stores with new paint and flooring, updated signage and the expansion and relocation of
several departments. Additionally, our new branding and advertising campaign, which focuses on
our 60 year history while emphasizing the new look and feel of Freds continued throughout the
quarter. During the second quarter of 2007 we embarked on two additional strategies to
enhance our customers experience when visiting our stores. The first involves a new extensive
market research program to determine customer preferences and expectations in a visit to a
Freds store and the second involves a new site selection and real estate program to determine
which locations best suit our customers.
The integration of the aforementioned strategies coupled with our unique store layout allows
us to offer our customers all the attractive elements of a discount dollar store, drug store
and mass merchant under one roof. By offering elements of all three types of businesses, we
are able to provide our customers with a ten minute Superstore experience in a smaller,
easier and more convenient store layout.
As discussed in our Form 10-K for the fiscal year ended February 3, 2007, we slowed our new
store growth in the first six months and will continue to do so through the remainder of the
year. This slow down in growth, coupled with the closing of unproductive stores, should have
a positive impact on the Companys operating margin over time. In the first six months of
2007, the Company opened 16 new stores and closed 16 stores. The majority of our new store
openings were in Alabama, Texas, and Mississippi. We did not enter into any new states during
the quarter. Additionally, we opened nine new pharmacies and closed four pharmacies during the
first six months of 2007.
The Company continued during the first six months to see paybacks on productivity
improvements and key technology initiatives. Some of these include continuing enhancement of
our point of sale and radio frequency (RF) store systems, refinement and upgrades to our
merchandise planning and allocation systems and process and productivity standards
improvements in our distribution centers. Pharmacy system improvements that enhance customer
service also continue to be a key initiative.
13
During the remainder of 2007, we intend to continue with capital improvements in
infrastructure, including new store expansion, distribution center upgrades and further
development of our information technology capabilities.
As previously reported, the Company expects an increase of 6 % to 12% in earnings per diluted
share for 2007. The Company bases this increase in estimated earnings for fiscal 2007 on the
following assumptions:
Comparable store sales are anticipated to increase in the range of 1% to 3% in the
third and fourth quarter.
The Company expects to open 14 to 19 more new stores, and 3 to 6 more new pharmacies,
and expects to close 4 to 9 more stores during the remainder of fiscal 2007, netting growth
in selling square footage in the range of 1% to 3% for the year.
Minimum wage legislation which went into effect on July 24, 2007 should benefit our
customers, thereby increasing our sales, which offset expenses of increased labor costs.
We anticipate additional expenses of approximately $0.3 million associated with
previously announced store closings.
Key factors that will be critical to the Companys future success include managing the growth
strategy for new stores and pharmacies, including the ability to open and operate efficiently,
maintaining high standards of customer service, maximizing efficiencies in the supply chain,
controlling working capital needs through improved inventory turnover, controlling the effects
of inflation, especially in regard to occupancy costs, increasing operating margin through
improved gross margin and leveraging operating costs, and generating adequate cash flow to
fund the Companys expansion.
Other factors that will affect Company performance in 2007 include the continuing management
of the impacts of the changing regulatory environment in which our pharmacy department
operates, especially the anticipated implementation of the federally approved change in
pricing of generic pharmaceuticals to Average Manufacturers Price (AMP), which could
negatively affect gross margin. Also, the Company experienced an initial negative impact in
selling, general and administrative expenses from the recent raising of the Federal minimum
wage; however, the increase should be a positive factor over time because it will directly
impact the disposable income of our primary customer base.
Our business is subject to seasonal influences, but has tended to experience less seasonal
fluctuation than many other retailers due to the mix of everyday basic merchandise and
pharmacy business. Our fiscal fourth quarter is typically the most profitable quarter
because it includes the Christmas selling season. The overall strength of the fourth
quarter is partially mitigated, however, by the inclusion of the month of January, which is
generally the least profitable month of the year.
CRITICAL ACCOUNTING POLICIES AND ESTIMATES
The Companys discussion and analysis of its financial condition and results of operations are
based upon the Companys condensed financial statements, which have been prepared in
accordance with accounting principles generally accepted in the United States. The critical
accounting matters that are particularly important to the portrayal of the Companys financial
condition and results of operations and require some of managements most difficult,
subjective and complex judgments are described in detail in the Companys Annual Report on
Form 10-K for the fiscal year ended February 3, 2007. The preparation of condensed financial
statements requires the Company to make estimates and judgments that affect the reported
amounts of assets, liabilities, revenue and expenses, and related disclosure of contingent
assets and liabilities. On an ongoing basis, the Company evaluates its estimates, including
those related to inventories, income taxes, insurance
reserves, contingencies and litigation. The Company bases its estimates on historical
experience and on various other assumptions that are believed to be reasonable under the
circumstances, the results of which form the basis for making judgments about the carrying
values of assets and liabilities that are not readily apparent from other sources. Actual
results may differ from these estimates under different assumptions or conditions. The only
material changes in critical
14
accounting policies during the twenty-six weeks ended August 4,
2007, was the adoption of FASB Interpretation No. 48 (FIN 48), Accounting for Uncertainty in
Income Taxes an Interpretation of FASB Statement No.109, which was discussed in detail in
Note 6 of the financial statements included elsewhere in this document.
The only material change in estimate during the twenty-six weeks ended August 4, 2007 was the
addition of certain Merchandise Planning, Information Technology and Human Resource costs to the
calculation used to estimate the costs capitalized as part of merchandise inventory. Previously,
these costs have not been included in the calculation used to estimate the costs capitalized as
part of merchandise inventory and the Company believes that their inclusion provides a more
complete and comprehensive merchandise inventory value. This change is discussed in more detail in
Note 3 of the financial statements included elsewhere in this document.
RESULTS OF OPERATIONS
Thirteen Weeks Ended August 4, 2007 and July 29, 2006
Net sales increased to $424.6 million in 2007 from $406.9 million in 2006, an increase of
$17.7 million or 4.3%. The increase was attributable to comparable store sales increases of
0.8% ($3.2 million) and sales by stores not yet included as comparable stores ($14.1
million). Sales to franchisees increased $.4 million in 2007 compared to the same quarter
last year. The sales mix for the period was 32.6% Pharmaceuticals, 23.8% Household Goods,
10.0% Apparel and Linens, 14.1% Food and Tobacco, 9.2% Paper and Cleaning Supplies, 8.2%
Health and Beauty Aids, and 2.1% Franchise. This compares with 33.0% Pharmaceuticals, 22.5%
Household Goods, 12.4% Apparel and Linens, 12.8% Food and Tobacco, 8.2% Health and Beauty
Aids, 9.0% Paper and Cleaning Supplies, and 2.1% Franchise for the same period last year.
Gross profit increased to 28.6% of sales in 2007 compared with 28.3% of sales in the
prior-year period. The improvement is primarily a result of controlling shrink in the
general merchandise and pharmacy departments, as well as pharmacy department benefits gained
through the shift from branded drugs to generics, which have a larger profit margin.
Selling, general and administrative expenses increased to $115.8 million in 2007 from $108.8
million in 2006. The increase in the quarter is primarily attributed to lease termination
costs related to store closings (0.20%), store expenses related to our store refresher
program (0.15%), additional advertising expenses related to our branding campaign (0.10%),
and insurance cost (0.05%). As a percentage of sales, expenses increased to 27.2% of sales
compared to 26.8% of sales last year.
For the second quarter of 2007, the Company incurred net interest expense of $0.2 million,
the same as in 2006.
For the second quarter of 2007, the effective income tax rate was 44.0%, as compared to 27.8%
in the second quarter of last year. The increase in the tax rate in the second quarter
resulted from a higher overall state income tax rate this year as well as the post-implementation
effect of FIN 48, Accounting for Uncertainty in Income Taxes.
Twenty-six Weeks Ended August 4, 2007 and July 29, 2006
Net sales
increased to $866.9 million in 2007 from $823.8 million in 2006, an increase of $43.1 million or 5.2%. The increase was attributable to comparable store sales
increases of 1.3% ($10.7 million) and sales by stores not yet included as comparable stores
($31.7 million). Sales to franchisees increased $0.7 million in 2007. The sales mix for the
period was 32.9% Pharmaceuticals, 23.4% Household Goods, 14.2% Food and Tobacco, 10.2%
Apparel and Linens, 9.0% Paper and Cleaning Supplies, 8.2% Health and Beauty Aids, and 2.1%
Franchise. This compares with 32.6% Pharmaceuticals, 22.3% Household Goods, 13.0% Apparel
and Linens, 13.1% Food and Tobacco, 8.7 % Paper and Cleaning Supplies, 8.2% Health and
Beauty Aids, and 2.1% Franchise for the same period last year.
For the twenty-six weeks ended August 4, 2007, we opened 16 new stores and 9 new pharmacies
and we closed 16 stores and 4 pharmacies.
Gross profit increased to 28.7% of sales in 2007 compared with 28.5% of sales in the
prior-year period. Gross profit margin for the first six months was favorably affected by
the same factors as listed for the second quarter.
Selling, general and administrative expenses increased to $231.6 million in 2007 from $217.6
million in 2006. As a percentage of sales, expenses increased to 26.7% of sales compared to
26.4% of sales last year. The increase in expenses as a percent to sales results primarily
from lease termination costs (.16%) and expenses related to the merchandise refresher program
(.10%).
15
For the first six months of 2007, we incurred net interest expense of $0.1 million as
compared to net interest expense of $0.2 million last year. The decrease in interest results
from better management of cash flow.
For the first six months of 2007, the effective income tax rate was 37.2%, compared with
31.8% for last year. The increase in the rate resulted primarily from the same issues as
mentioned in the quarter. We anticipate the tax rate for the remaining two quarters of 2007
to be in the 36% to 38% range.
LIQUIDITY AND CAPITAL RESOURCES
Due to the seasonality of our business and the continued increase in the number of stores and
pharmacies, inventories are generally lower at year-end than at each quarter-end of the
following year.
Cash used in operating activities totaled $15.8 million during the twenty-six week period
ended August 4, 2007. Cash was primarily used to increase inventories by approximately $43.5
million in the first six months of 2007. This increase was primarily attributable to 16 new
stores and increases in our basic product inventories to improve in-stock positions, and
additional inventories related to the new stationery program and check-out aisle resets.
Cash used in investing activities totaled $12.5 million, and consisted primarily of capital
expenditures associated with the store and pharmacy expansion program ($6.2 million),
acquisition of LLCs owning land and buildings ($0.4 million), expenditures related to the
Store Refresher Program ($4.9 million) and technology and other corporate expenditures ($1.2
million). During the first six months of 2007, we opened 16 stores, closed 16 stores, opened
9 pharmacies, and closed 4 pharmacies. We expect to open 8 to 10 stores in the third quarter
and approximately 30 to 35 stores for the year. In 2007, the Company is planning capital
expenditures totaling approximately $31.9 million. Expenditures are planned totaling
approximately $24.7 million for upgrades, remodels, or new
stores and pharmacies or acquisitions of land and buildings; $5.2
million for technology upgrades, $2.0 million for distribution center equipment and capital
replacements. In addition, the Company also plans expenditures of $2.6 million for the
acquisition of customer lists and other pharmacy related items. Depreciation expense for 2007
will be approximately $29 million.
Cash provided by financing activities totaled $28.2 million and included $30.1 million of
borrowings under the Companys revolving credit agreement for inventory needs. There were
$32.2 million in borrowings against our revolving line of credit outstanding at August 4,
2007 and $2.2 million in borrowings against our revolving line of credit outstanding at
February 3, 2007.
We believe that sufficient capital resources are available in both the short-term
and long-term through currently available cash and cash generated from future
operations and, if necessary, the ability to obtain additional financing.
CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION
Other than statements based on historical facts, many of the matters discussed in this
Form 10-Q relate to events which we expect or anticipate may occur in the future. Such
statements are defined as forward-looking statements under the Private Securities
Litigation Reform Act of 1995 (the Reform Act), 15 U.S.C.A. Sections 77z-2 and 78u-5
(Supp. 1996). The Reform Act created a safe harbor to protect companies from
securities law liability in connection with forward-looking statements. We intend to
qualify both our written and oral forward-looking statements for protection under the
Reform Act and any other similar safe harbor provisions.
The words believe, anticipate, project, plan, expect, estimate,
objective, forecast, goal, intend, will likely result, or will continue and
similar expressions generally identify forward-looking statements. All forward-looking
statements are inherently uncertain, and concern matters that involve risks and other
factors that may cause the
16
actual performance of the Company to differ materially from
the performance expressed or implied by these statements. Therefore, forward-looking
statements should be evaluated in the context of these uncertainties and risks,
including but not limited to:
|
o |
|
Economic and weather conditions which affect buying patterns of our
customers and supply chain efficiency. |
|
|
o |
|
Changes in consumer spending and our ability to anticipate buying
patterns and implement appropriate inventory strategies. |
|
|
o |
|
Continued availability of capital and financing. |
|
|
o |
|
Competitive factors. |
|
|
o |
|
Changes in reimbursement practices for pharmaceuticals. |
|
|
o |
|
Governmental regulation. |
|
|
o |
|
Increases in fuel and utility rates. |
|
|
o |
|
other factors affecting business beyond our control, including (but not
limited to) those discussed under Part 1, ITEM 1A Risk Factors of the Companys
Annual Report on Form 10-K for the fiscal year ended February 3, 2007. |
Consequently, all forward-looking statements are qualified by this cautionary statement. We
undertake no obligation to update any forward-looking statement to reflect events or
circumstances arising after the date on which it was made.
Item 3.
QUANTITATIVE AND QUALITATIVE DISCLOSURE ABOUT MARKET RISK
We have no holdings of derivative financial or commodity instruments as of August 4,
2007. We are exposed to financial market risks, including changes in interest rates. All
borrowings under our Revolving Credit Agreement bear interest at 1.5% below prime rate or a
LIBOR-based rate. An increase in interest rates of 100 basis points would not significantly
affect our income. All of our business is transacted in U.S. dollars and, accordingly,
foreign exchange rate fluctuations have not had a significant impact on us, and they are not
expected to in the foreseeable future.
Item 4.
CONTROLS AND PROCEDURES
(a) Disclosure Controls and Procedures. As of the end of the period covered by this
report, the Company carried out an evaluation, under the supervision and with the
participation of our Chief Executive Officer and Chief Financial Officer, of the
effectiveness of the Companys disclosure controls and procedures (as defined in Rules
13a-15(e) under the Securities Exchange Act of 1934, as amended (the Exchange Act)). Based
on that evaluation, the Chief Executive Officer and the Chief Financial Officer, concluded
that, as of the date of their evaluation, the Companys disclosure controls and procedures
are effective in timely alerting them to material information required to be included in the
Companys periodic SEC reports, subject to the effectiveness of the Companys internal
control over financial reporting. Consistent with the suggestion of the Securities and
Exchange Commission, the Company has formed a Disclosure Committee consisting of key Company
personnel designed to review the accuracy and
completeness of all disclosures made by the Company.
(b) Changes in Internal Control over Financial Reporting. There have been no changes in
the Companys internal control over financial reporting that occurred during the Companys
second fiscal quarter that have materially affected or are reasonably likely to materially
affect the Companys internal control over financial reporting.
17
PART II. OTHER INFORMATION
Item 1. LEGAL PROCEEDINGS
The Company is party to several pending legal proceedings and claims arising in the
normal course of business including those mentioned in Part I Item 3. Legal
Proceedings in the Annual Report on Form 10-K for the fiscal year ended February 3,
2007. Although the outcome of the proceedings and claims cannot be determined with
certainty, management of the Company is of the opinion that it is unlikely that these
proceedings and claims will have a material adverse effect on the financial statements
as a whole. However, litigation involves an element of uncertainty. There can be no
assurance that pending lawsuits will not consume the time and energy of our management,
or that future developments will not cause these actions or claims, individually or in
aggregate, to have a material adverse effect on the financial statements as a whole. We
intend to vigorously defend or prosecute each pending lawsuit.
Item 1A. RISK FACTORS
The risk factors listed in Part I Item 1A. Risk Factors in the Annual Report on Form 10-K
for the fiscal year ended February 3, 2007, should be considered with the information
provided elsewhere in this Quarterly Report on Form 10-Q, which could materially adversely
affect the business, financial condition or results of operations. There have been no
material changes to the risk factors as previously disclosed in such Annual Report on Form
10-K.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.
On July 16, 2007 and July 20, 2007, we sold in a private placement an aggregate of
32,578 shares of Class A common stock to Summit Properties, LLC (Summit)
pursuant to the exemptions from registration provided in Section 4(2) of the
Securities Act of 1933, as amended (the Act), and Rule 506 of Regulation D
promulgated thereunder. The shares were issued in connection with our acquisition
of the membership interests of certain LLCs and related real estate rights. The
shares have subsequently been registered under the Act. We will not receive any
proceeds from the sale of these shares.
The private placement that we made in reliance on the exemptions from registration
under Section 4(2) of the Act and Rule 506 of Regulation D thereunder did not
involve any public offering of common stock. In addition, Summit provided us with
written representations that it was an accredited investor within the meaning of
Rule 501(e) of Regulation D, that it was a sophisticated investor and that it had
the knowledge and experience necessary to evaluate the risks and merits of the
investment in our common stock. In addition, Summit was solicited on a private
and confidential basis in a manner not involving any general solicitation or
advertising in compliance with Regulation D.
Item 4. Submission of Matters to a Vote of Securities Holders
The Annual Meeting of the Shareholders of Freds, Inc. was held on June 20, 2007. Michael J.
Hayes, John R. Eisenman, Roger T. Knox, John D. Reier, Thomas H. Tashjian, B. Mary McNabb and
Michael T. McMillan were elected as directors of the Company. The shareholders also ratified
the appointment of BDO Seidman, LLP as our registered public accounting firm for the fiscal
year ending February 2, 2008. The shareholders also rejected the shareholder proposal
regarding vendor
code of conduct.
18
The results of the voting were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Abstain/ |
|
|
|
|
|
|
For |
|
Against |
|
Withheld |
|
Broker Non-Vote |
Election of Directors: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Michael J. Hayes |
|
|
33,434,925 |
|
|
|
|
|
|
|
2,863,107 |
|
|
|
3,769,486 |
|
John R. Eisenman |
|
|
33,921,972 |
|
|
|
|
|
|
|
2,376,060 |
|
|
|
3,769,486 |
|
Roger T. Knox |
|
|
33,919,077 |
|
|
|
|
|
|
|
2,378,955 |
|
|
|
3,769,486 |
|
John D. Reier |
|
|
34,550,402 |
|
|
|
|
|
|
|
1,747,630 |
|
|
|
3,769,486 |
|
Thomas H. Tashjian |
|
|
34,171,572 |
|
|
|
|
|
|
|
2,126,460 |
|
|
|
3,769,486 |
|
B. Mary McNabb |
|
|
34,994,351 |
|
|
|
|
|
|
|
1,303,681 |
|
|
|
3,769,486 |
|
Michael T. McMillan |
|
|
34,997,352 |
|
|
|
|
|
|
|
1,300,680 |
|
|
|
3,769,486 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Appointment of
BDO Seidman, LLP |
|
|
36,206,165 |
|
|
|
91,867 |
|
|
|
3,769,486 |
|
|
|
|
|
Shareholder Proposal |
|
|
2,907,172 |
|
|
|
29,394,444 |
|
|
|
7,765,902 |
|
|
|
|
|
Item 6. Exhibits
Exhibits:
|
|
|
|
|
|
|
|
|
|
31.1 |
|
|
Certification of Chief Executive Officer. |
|
|
|
|
|
|
|
|
|
|
31.2 |
|
|
Certification of Chief Financial Officer. |
|
|
|
|
|
|
|
|
|
|
32. |
|
|
Certification of Chief Executive Officer and Chief
Financial Officer pursuant to rule 13a14(b) under the Securities
Exchange Act of 1934 and 18 U.S.C. Section 1350. |
19
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly
caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|
|
|
|
|
|
FREDS, INC.
|
|
Date: September 13, 2007 |
/s/ Michael J. Hayes
|
|
|
Michael J. Hayes |
|
|
Chief Executive Officer |
|
|
|
|
|
Date: September 13,
2007 |
/s/ Jerry A. Shore
|
|
|
Jerry A. Shore |
|
|
Chief Financial Officer |
|
20